Trial Details
TERMINATEDBasic Information
| Clinical ID | c4665 |
|---|---|
| Identifier | NCT00171431 |
| Trial Title | The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Constipation Predominant|Irritable Bowel Syndrome (IBS-C) |
| Interventions | DRUG: Tegaserod |
Participant Information
| Sponsor | Novartis Pharmaceuticals |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2004-11 |
|---|---|
| Primary Completion Date | 2006-05 |
| Completion Date | 2006-05 |